swelling red spot got bigger and biggerand then went away and came back, it is reoccurring; swelling red spot got bigger and biggerand then went away and came back, it is reoccurring; He did not receive the 2nd shot.; The next morning he had chest pain.; he has palpitations/his heart rate is kind of up and down; when he tries to go up a slight incline, there is a weight on his chest; burning sensation on his chest.; His blood pressure went sky high, and then it went away./Ever since then, he has been having high blood pressure,; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (His blood pressure went sky high, and then it went away./Ever since then, he has been having high blood pressure,), CHEST PAIN (The next morning he had chest pain.), PALPITATIONS (he has palpitations/his heart rate is kind of up and down), CHEST DISCOMFORT (when he tries to go up a slight incline, there is a weight on his chest) and CHEST PAIN (burning sensation on his chest.) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced HYPERTENSION (His blood pressure went sky high, and then it went away./Ever since then, he has been having high blood pressure,) (seriousness criterion medically significant). On 03-Feb-2021, the patient experienced CHEST PAIN (The next morning he had chest pain.) (seriousness criterion medically significant), PALPITATIONS (he has palpitations/his heart rate is kind of up and down) (seriousness criterion medically significant), CHEST DISCOMFORT (when he tries to go up a slight incline, there is a weight on his chest) (seriousness criterion medically significant) and CHEST PAIN (burning sensation on his chest.) (seriousness criterion medically significant). On an unknown date, the patient experienced ERYTHEMA (swelling red spot got bigger and biggerand then went away and came back, it is reoccurring), SWELLING (swelling red spot got bigger and biggerand then went away and came back, it is reoccurring) and PRODUCT DOSE OMISSION ISSUE (He did not receive the 2nd shot.). At the time of the report, HYPERTENSION (His blood pressure went sky high, and then it went away./Ever since then, he has been having high blood pressure,), ERYTHEMA (swelling red spot got bigger and biggerand then went away and came back, it is reoccurring) and SWELLING (swelling red spot got bigger and biggerand then went away and came back, it is reoccurring) had not resolved, CHEST PAIN (The next morning he had chest pain.), PALPITATIONS (he has palpitations/his heart rate is kind of up and down), CHEST DISCOMFORT (when he tries to go up a slight incline, there is a weight on his chest) and CHEST PAIN (burning sensation on his chest.) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (He did not receive the 2nd shot.) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Heart rate: high (High) heart rate was extremely high (180BPM) which lasted for a half hour.. On 03-Feb-2021, Heart rate: high (High) When he was in the ER, his heart rate was at 200BPM at least.  ended up in the emergency room since his heart rate was going extremely fast.         Concomitant product use was not provided by the reporter.  No treatment information was provided.  Company comment: This report refers to a case of Product dose omission issue for mRNA-1273, with AEs. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.; Sender's Comments: This report refers to a case of Product dose omission issue for mRNA-1273, with AEs. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.